Summary
Cytomegalvirus (CMV) establishes a latent infection in its host; however, the organ sites of viral latency and its mechanism still remain to be fully clarified. To elucidate this issue, a latent infection with murine (M) CMV was attempted to induce in mice and the organ sites of the latent viral genome were examined for more than one year by a polymerase chain reaction (PCR). As a result, latent MCMV DNA was detectable in both the lung and the spleen as late as 59 weeks after infection. The heart was also observed to be a target organ of latent MCMV DNA, though the amount of viral DNA was much less than that seen in the lung and spleen. In germfree (GF) mice, on the other hand, no such latent viral DNA was observed in the spleens, while it was seen, but to a significantly smaller degree, in the lungs and the hearts than in the same organs of specific pathogen-free (SPF) mice. The amount of infectious virions generated in the host appeared to be almost equal between the GF and SPF mice. The above findings therefore suggest that the spleen, lung and heart are target organs for MCMV latency and the indigenous bacterial flora, which are not colonizing in GF mice, play an important role in the establishment of such viral latency in SPF mice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahmed R, Stevens JG (1990) Viral persistence. In: Fields BN, Knipe DM (eds) Virology, 2nd ed. Raven Press, New York, pp 241–265
Alford CA, Britt WJ (1990) Cytomegalovirus. In: Fields BN, Knipe DM (eds) Virology, 2nd ed. Raven Press, New York, pp 1981–2009
Balthesen M, Msserle M, Reddehase MJ (1993) Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 67: 5360–5366
Collins T, Pomeroy C, Jordan MC (1993) Detection of latent cytomegalovirus DNA in diverse organs of mice. J Infect Dis 168: 725–729
Dummer JS, Hardy A, Poorsattar A, Ho M (1983) Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation 36: 259–267
Ebeling A, Keil GM, Knust E, Koszinowski UH (1983) Molecular cloning and physical mapping of murine cytomegalovirus DNA. J Virol 47: 421–433
Fauci AS (1988) The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239: 617–622
Gotschlich EC (1993) Immunity to extracellular bacteria. In: Paul WE (ed) Fundamental immunology, 3rd ed. Raven Press, New York, pp 1287–1308
Henson D, Strano AJ (1972) Mouse cytomegalovirus: necrosis of infected and morphologically normal submaxillary gland acinar cells during termination of chronic infection. Am J Pathol 68: 183–195
Ho M (1991) Observations from transplantation contributing to the understanding of pathogenesis of CMV infection. Transplant Proc 23 [Suppl 3]: 104–109
Hudson JB (1979) The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections. Arch Virol 62: 1–29
Jonjic S, Pavic I, Lucin P, Rukavina D, Koszinowski UH (1990) Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes. J Virol 64: 5457–5464
Jordon MC, Mar V (1982) Spontaneous activation of murine cytomegalovirus from murine spleen explants. J Clin Invest 70: 762–768
Jordan MC, Shanley JD, Stevens JG (1977) Immunosuppression reactivates and disseminates latent murine cytomegalovirus. J Gen Virol 37: 419–425
Jordan MC, Takagi JL, Stevens JG (1981) Activation of latent murine cytomegalvoirus in vivo and in vitro: a pathogenic role for acute infection. J Infect Dis 145: 699–705
Klotman ME, Starnes D, Hamilton JD (1985) The source of murine cytomegalovirus in mice receiving kidney allografts. J Infect Dis 152: 1192–1196
Koga Y, Tanaka K, Lu Y-Y, Ohtsu M, Sasaki M, Kimura G, Nomoto K (1994) Priming of immature thymocytes to CD3-mediated apoptosis by infection with murine cytomegalovirus. J Virol 68: 4322–4328
Koszinowski UH, Del Val M, Reddehase MJ (1990) Cellular and molecular basis of the protective immune response to cytomegalovirus infection. Curr Topics Microbiol Immunol 154: 189–220
Leung WCT, Hashimoto K (1986) Modification of susceptibility to Klebsiella pneumoniae during murine cytomegalovirus infection. Microbiol Immunol 30: 761–776
Leung WCT, Hata J, Hashimoto K (1986) Murine cytomegalovirus infection model in Balb/c mice- 2. Pericarditis with myocardial involvement during virus infection. Tokai J Exp Clin Med 11: 303–311
MacDonald TT, Carter PB (1979) Requirement for a bacterial flora before mice generate cells capable of mediating the delayed hypersensitivity reaction to sheep red blood cells. J Immunol 122: 2624–2629
Meyers JD, Flournoy N, Thomas ED (1986) Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 153: 478–488
Paya CV, Hermans PE, Wiesner RH, Ludwig J, Smith TF, Rakela J, Krom RAF (1989) Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations. J Infect Dis 160: 752–758
Peterson PK, Balfour HH Jr, Marker SC, Fryd DS, Howard RJ, Simmons RL (1980) Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine 59: 283–300
Pomeroy C, Hillerren PJ, Jordan MC (1991) Latent murine cytomegalovirus DNA in splenic stromal cells of mice. J Virol 65: 3330–3334
Reddehase MJ, Balthesen M, Rapp M, Jonjic S, Pavic I, Koszinowski UH (1994) The condition of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med 179: 185–193
Reddehase MJ, Rothbard JB, Koszinowski UH (1989) A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 337: 651–653
Rice GPA, Schrier RD, Oldstone MBA (1984) Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc Natl Acad Sci USA 81: 6134–6138
Roizman B, Sears AE (1987) An inquiry into the mechanism of herpes simplex virus latency. Annu Rev Microbiol 41: 543–571
Schrier RD, Nelson JA, Oldstone MBA (1985) Detection of human cytomegalovirus in peripheral blood lymphocytes in natural infection. Science 230: 1048–1051
Shanley JD, Jordan MC, Cook ML, Stevens JG (1979) Pathogenesis of reactivated latent murine cytomegalovirus infection. Am J Pathol 95: 67–80
Umehara K, Yamanaka M, Hashimoto K, Sasaki S (1984) Nitrogen retention in germ-free and conventional mice reared on an antigen-free diet and the significance of the appearance of protein nitrogen in their feces. Exp Anim 33: 77–84
Wannemuehler MJ, Kiyono H, Babb JL, Michalek SM, McGhee JR (1982) Lipopolysaccharide (LPS) regulation of the immune response. J Immunol 129: 959–965
Wilson EJ, Medearis DN, Barrett V, Rubin RH (1985) Activation of latent murine cytomegalovirus in cardiac explant and cell cultures. J Infect Dis 152: 625–626
Yuhasz SA, Dissette VB, Cook ML, Stevens JG (1994) Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice. Virology 202: 272–280
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsuzawa, H., Shimizu, K., Okada, K. et al. Analysis of target organs for the latency of murine cytomegalovirus DNA using specific pathogen free and germfree mice. Archives of Virology 140, 853–864 (1995). https://doi.org/10.1007/BF01314962
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01314962